Fake Avastin shows very little protects drug supply
 |
| A worker makes its way on a bridge at Swiss pharmaceutical company Roche plant in Basel |
NEW YORK (Reuters) - As drug counterfeiters step up their sales of bogus medicines, global health regulators have few protections in place to prevent them from reaching patients, and new laws aimed at addressing the problem could be years away. Scrutiny of the supply chain has grown since fake versions of Roche's multibillion-dollar cancer drug Avastin turned up at U.S. oncology practices late last year, sparking an international investigation that so far stretches from southern California back to Turkey with a stopover in a Cairo suburb. ... read more..
source:http://yhoo.it/z2DKNf
No comments:
Post a Comment